NDC 58602-833 – Guaifenesin and Pseudoephedrine HCl

Guaifenesin 600 mg/1; Pseudoephedrine Hydrochloride 60 mg/1 · Tablet, Extended Release · Oral

Human Otc Drug

Product NDC58602-833

Product details

Brand name
Guaifenesin and Pseudoephedrine HCl
Generic name
Guaifenesin and Pseudoephedrine HCl
Labeler
Aurohealth LLC
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA213203
Marketed since
March 25, 2020
Listing expires
December 31, 2026
Pharmacologic class
Expectorant; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Guaifenesin and Pseudoephedrine HCl →

Package NDC codes (2)

Package NDCDescriptionSince
58602-833-121 BLISTER PACK in 1 CARTON (58602-833-12) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMar 25, 2020
58602-833-172 BLISTER PACK in 1 CARTON (58602-833-17) / 18 TABLET, EXTENDED RELEASE in 1 BLISTER PACKMar 25, 2020

Other Guaifenesin and Pseudoephedrine HCl products